Completed PHASE4 INTERVENTIONAL 2-arm NCT01773005

Caldolor Versus Caldolor Plus OFIRMEV in Total Knee or Hip Arthroplasty Surgeries

A Single Center, Randomized, Open-Label Trial to Compare the Safety and Efficacy of Caldolor Used Singly and in Combination With Ofirmev in Total Knee or Hip Arthroplasty Surgery Patients

Sponsor: Anita Gupta

Conditions Pain

Interventions Caldolor Ofirmev

Updated 5 times since 2017 Last updated: Feb 26, 2016 Started: Dec 31, 2012 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01773005, this PHASE4 trial focuses on Pain and remains completed. Sponsored by Anita Gupta, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Anita Gupta
Cumberland Pharmaceuticals

Data source: Hahnemann University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States